{"id":"https://openalex.org/W2302192178","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3017","title":"Correlation of T-cell response, clinical activity and regulatory T-cell levels in renal cell carcinoma patients treated with IMA901, a novel multi-peptide vaccine","display_name":"Correlation of T-cell response, clinical activity and regulatory T-cell levels in renal cell carcinoma patients treated with IMA901, a novel multi-peptide vaccine","alternate_titles":[],"publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2302192178","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3017","mag":"2302192178"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.3017","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3017","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3017","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2302192178"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067589440","display_name":"Harpreet Singh\u2010Jasuja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Singh-Jasuja","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007396551","display_name":"Steffen Walter","orcid":"https://orcid.org/0000-0002-0249-2622","observed_orcids":["https://orcid.org/0000-0002-0249-2622"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Walter","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085265624","display_name":"Toni Weinschenk","orcid":"https://orcid.org/0000-0001-8644-0290","observed_orcids":["https://orcid.org/0000-0001-8644-0290"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Weinschenk","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Mayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Mayer","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111761299","display_name":"Pierre Yves Dietrich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Y. Dietrich","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091833311","display_name":"Michael D. Staehler","orcid":"https://orcid.org/0000-0002-4574-6522","observed_orcids":["https://orcid.org/0000-0002-4574-6522"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Staehler","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112077313","display_name":"A. Stenzl","orcid":"https://orcid.org/0009-0004-4286-6563","observed_orcids":["https://orcid.org/0009-0004-4286-6563"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Stenzl","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012626247","display_name":"Stefan Stevanovi\u0107","orcid":"https://orcid.org/0000-0001-7430-1437","observed_orcids":["https://orcid.org/0000-0001-7430-1437"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Stevanovic","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090153362","display_name":"Hans\u2010Georg Rammensee","orcid":"https://orcid.org/0000-0003-1614-2647","observed_orcids":["https://orcid.org/0000-0003-1614-2647"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Rammensee","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]},{"author_position":"last","author":{"id":null,"display_name":"J. Frisch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["CH","DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Frisch","raw_affiliation_strings":["immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"immatics biotechnologies, Tuebingen, Germany; University Hospital of Geneva, Geneva, Switzerland; Ludwig- Maximilians University, Muenchen, Germany; University of Tuebingen, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210106256","https://openalex.org/I4210138096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"3017","last_page":"3017"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multipeptide-vaccine","display_name":"multipeptide vaccine","score":0.7260000109672546},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/tumor-associated-peptides","display_name":"tumor-associated peptides","score":0.8600000143051147},{"id":"https://openalex.org/keywords/t-cell-response","display_name":"T cell response","score":0.7979999780654907},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9860000014305115},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.699999988079071},{"id":"https://openalex.org/keywords/hla-a-02","display_name":"HLA-A*02","score":0.8740000128746033},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5649999976158142},{"id":"https://openalex.org/keywords/clinical-benefit","display_name":"clinical benefit","score":0.5450000166893005},{"id":"https://openalex.org/keywords/ifn-gamma-elispot","display_name":"IFN-gamma ELISPOT","score":0.781000018119812},{"id":"https://openalex.org/keywords/gm-csf-adjuvant","display_name":"GM-CSF adjuvant","score":0.8100000023841858},{"id":"https://openalex.org/keywords/tumor-antigens","display_name":"tumor antigens","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2779053233","wikidata":"https://www.wikidata.org/wiki/Q731235","display_name":"ELISPOT","level":4,"score":0.9096470475196838},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.778508186340332},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.6703310012817383},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.601420521736145},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5952437520027161},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5691163539886475},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5052421689033508},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4847235679626465},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.48249053955078125},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4293527603149414},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4275379180908203},{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.4204097390174866},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.4177740812301636},{"id":"https://openalex.org/C2776789287","wikidata":"https://www.wikidata.org/wiki/Q7166532","display_name":"Peptide vaccine","level":4,"score":0.4117884635925293},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34638217091560364},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34509560465812683},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.2427562177181244}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.3017","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.3017","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.3017","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2522729691","https://openalex.org/W2281861179","https://openalex.org/W2082830752","https://openalex.org/W2087821529","https://openalex.org/W4307502239","https://openalex.org/W2242950936","https://openalex.org/W2086474377","https://openalex.org/W4242712794","https://openalex.org/W1995806513","https://openalex.org/W2029087888"],"abstract_inverted_index":{"3017":[0],"Background:":[1],"Cancer":[2],"vaccines":[3],"have":[4],"been":[5],"able":[6],"to":[7,186,231,302,340],"induce":[8],"T-cell":[9,86,154,182,205,270,293,312],"responses":[10,21,155,183,206,230,256,271,294],"in":[11,54,83,114,173,220,272,307,322,331],"cancer":[12,39,326],"patients":[13,111,227],"but":[14],"rarely":[15],"demonstrated":[16],"a":[17,31,37,74,115,142,235,273],"correlation":[18,251,290],"of":[19,30,65,76,137,192,223,252,275,282,291,311,325],"immune":[20,152],"with":[22,35,257,295],"clinical":[23,237,259,280,296],"benefit.":[24,297],"Here,":[25],"we":[26,319],"present":[27],"immunological":[28],"results":[29],"phase":[32],"1":[33,91],"study":[34,119,247],"IMA901,":[36],"therapeutic":[38],"vaccine":[40,327],"based":[41],"on":[42,124],"multiple":[43,202,229,292],"novel":[44],"synthetic":[45],"tumor-associated":[46],"peptides":[47],"(TUMAP)":[48],"identified":[49],"as":[50,151],"being":[51],"naturally":[52],"presented":[53],"primary":[55,67],"renal":[56],"cell":[57,168],"carcinoma":[58],"(RCC)":[59],"tissues.":[60],"Methods:":[61],"The":[62],"HLA":[63,160],"peptidome":[64],"32":[66],"RCC":[68,110,277],"samples":[69],"was":[70,264],"systematically":[71],"investigated":[72],"using":[73,156],"combination":[75],"mass":[77],"spectrometry,":[78],"gene":[79],"expression":[80],"profiling":[81],"and":[82,90,103,120,133,147,159,163,215,242],"vitro":[84,332],"human":[85],"assays.":[87],"9":[88,97],"HLA-A*02-":[89],"HLA-DR-":[92],"restricted":[93],"TUMAPs":[94,203,232],"derived":[95],"from":[96],"different":[98],"tumor":[99],"antigens":[100,328],"were":[101,112,171,184,207,216],"selected":[102],"designated":[104],"IMA901.":[105],"28":[106],"HLA-A*02-positive":[107],"stage":[108],"III/IV":[109],"enrolled":[113],"single":[116],"arm,":[117],"multicenter":[118],"received":[121],"8":[122],"vaccinations":[123],"days":[125],"1,":[126],"2,":[127],"3,":[128],"8,":[129],"15,":[130,212],"22,":[131],"36,":[132],"64":[134],"each":[135],"consisting":[136],"4.5":[138],"mg":[139],"IMA901":[140,267],"(including":[141],"HBV-derived":[143],"viral":[144],"marker":[145,189,254],"peptide)":[146],"75":[148],"\u03bcg":[149],"GM-CSF":[150],"adjuvant.":[153],"IFN-\u03b3":[157],"ELISPOT":[158],"multimer":[161],"analysis":[162],"CD4+":[164,298],"Foxp3+":[165,299],"regulatory":[166],"T":[167],"(Treg)":[169],"levels":[170,245,263],"measured":[172],"peripheral":[174],"blood.":[175],"Results:":[176],"In":[177],"vivo":[178,323],"IMA901-":[179],"induced":[180,269],"specific":[181],"detected":[185],"the":[187,221,288,309],"HBV":[188,253],"peptide":[190,255],"(52%":[191],"27":[193],"evaluable":[194],"patients),":[195],"at":[196,210,246],"least":[197],"one":[198],"TUMAP":[199],"(74%)":[200],"or":[201,261],"(30%).":[204],"detectable":[208],"already":[209],"day":[211],"peaked":[213],"subsequently":[214],"sustainable":[217],"until":[218],"follow-up":[219],"majority":[222,274],"patients.":[224,278],"Most":[225],"importantly,":[226],"eliciting":[228],"significantly":[233],"showed":[234],"higher":[236],"benefit":[238,260],"rate":[239],"(SD+PR;":[240],"p=0.018)":[241],"lower":[243],"Treg":[244,262],"onset":[248],"(p=0.016).":[249],"No":[250,336],"either":[258],"observed.":[265],"Conclusions:":[266],"rapidly":[268],"advanced":[276],"A":[279],"mode":[281],"action":[283],"is":[284],"strongly":[285],"supported":[286],"by":[287,329],"significant":[289,337],"Tregs":[300],"seem":[301],"play":[303],"an":[304],"active":[305],"role":[306],"limiting":[308],"broadness":[310],"responses.":[313],"Furthermore,":[314],"our":[315,330],"data":[316],"suggest":[317],"that":[318],"can":[320],"predict":[321],"immunogenicity":[324],"drug":[333],"discovery":[334],"approach.":[335],"financial":[338],"relationships":[339],"disclose.":[341]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2302192178","counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
